| |
|
|
|
Cytosorbents Corporation  
|
|
8.2 -0.08 (-0.01%) |
02-19 15:41 |
|
Open: |
8.38 |
Pre close: |
8.28 |
Target:
|
9.88
|
|
High: |
8.45 |
Low: |
8.148 |
Resistance:
|
8.46
9.88
|
|
Volume: |
78,681 |
Market Cap: |
260M |
Support:
|
7.37
6.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.22
 |
MACD |
MACD(12,26):
|
0.11 |
|
MA(20): |
7.71 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
9.33  |
Stochastic Oscillator |
%K(14,3):
|
84.31 |
|
MA(250): |
9.94 |
%D(3): |
84.21 |
|
Average Volume(K) |
3-Month: |
18105
|
52-Week |
High:
|
14.95 |
|
10-Days: |
11991 |
Low: |
6.67 |
|
RSI |
RSI(14):
|
56.67 |
Change(%): |
13.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.510 |
Return on Equity (ttm) |
-101.6 |
Shares Out. (M) |
31.65 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-53.2 |
Shares Float (M) |
12.41 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
50.2 |
% Held by Institutions |
37.20 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13.060 |
EBITDA (p.s.) |
0.000 |
P/E |
-16.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.63 |
|
Profit Margin |
-79.88 |
Operating Cash Flow
(M) |
-8.54 |
P/S |
373470016.00 |
|
Operating Margin |
-65.52 |
Levered Free Cash Flow
(M) |
-6.19 |
P/CF |
-30.61 |
|
|
|
|
|
|
